Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.
Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G, Scheibenbogen C, Squarcina P, Cova A, Camerini R, Lewis JJ, Srivastava PK, Parmiani G. Rivoltini L, et al. Among authors: carrabba m. J Immunol. 2003 Oct 1;171(7):3467-74. doi: 10.4049/jimmunol.171.7.3467. J Immunol. 2003. PMID: 14500642
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
Belli F, Testori A, Rivoltini L, Maio M, Andreola G, Sertoli MR, Gallino G, Piris A, Cattelan A, Lazzari I, Carrabba M, Scita G, Santantonio C, Pilla L, Tragni G, Lombardo C, Arienti F, Marchianò A, Queirolo P, Bertolini F, Cova A, Lamaj E, Ascani L, Camerini R, Corsi M, Cascinelli N, Lewis JJ, Srivastava P, Parmiani G. Belli F, et al. Among authors: carrabba m. J Clin Oncol. 2002 Oct 15;20(20):4169-80. doi: 10.1200/JCO.2002.09.134. J Clin Oncol. 2002. PMID: 12377960 Clinical Trial.
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.
Rivoltini L, Carrabba M, Huber V, Castelli C, Novellino L, Dalerba P, Mortarini R, Arancia G, Anichini A, Fais S, Parmiani G. Rivoltini L, et al. Among authors: carrabba m. Immunol Rev. 2002 Oct;188:97-113. doi: 10.1034/j.1600-065x.2002.18809.x. Immunol Rev. 2002. PMID: 12445284 Review.
T-cell recognition of melanoma-associated antigens.
Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N, Parmiani G. Castelli C, et al. Among authors: carrabba m. J Cell Physiol. 2000 Mar;182(3):323-31. doi: 10.1002/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#. J Cell Physiol. 2000. PMID: 10653598 Review.
Cytokines in cancer therapy.
Parmiani G, Rivoltini L, Andreola G, Carrabba M. Parmiani G, et al. Among authors: carrabba m. Immunol Lett. 2000 Sep 15;74(1):41-4. doi: 10.1016/s0165-2478(00)00247-9. Immunol Lett. 2000. PMID: 10996626 Review.
Cancer vaccines.
Carrabba M, Parmiani G, Rivoltini L. Carrabba M, et al. Tumori. 2000 Sep-Oct;86(5 Suppl 2):S33-7. Tumori. 2000. PMID: 11195301 Review. No abstract available.
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.
Dodero A, Carrabba M, Milani R, Rizzo E, Raganato A, Montefusco V, Farina L, Milanesi M, Longoni P, Carlo-Stella C, Corradini P. Dodero A, et al. Among authors: carrabba m. Exp Hematol. 2005 Aug;33(8):920-7. doi: 10.1016/j.exphem.2005.05.009. Exp Hematol. 2005. PMID: 16038785 Free article.
252 results